EFFICACY, SAFETY AND TOLERABILITY OF A NEW 10% INTRAVENOUS IMMUNOGLOBULIN FOR THE TREATMENT OF PRIMARY IMMUNODEFICIENCIES

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies

We report here the results of a phase 3 study to assess the efficacy, safety, and tolerability of GC5107, a new 10% liquid intravenous immunoglobulin (IVIG) in preventing serious bacterial infections in patients with primary immunodeficiency (ClinicalTrials.gov: NCT02783482).Over a 12-month study period, 49 patients aged 3 to 70 years with a confir

read more



Nevus lipomatosus cutaneous superficialis: An unusual presentation

Nevus lipomatosus cutaneous superficialis (NLCS) is an uncommon benign hamartomatous condition characterized by the presence of mature ectopic adiopocytes in the dermis.It was first reported by Hoffman and Zurhelle in 1921.Clinically they areit is classified into two forms.The classical form is characterized by groups of multiple, non-tender, soft,

read more